Nathaniel "Sandy" Paige
Nathaniel “Sandy” Paige is the CEO of Explora BioLabs. Paige was most recently Director of International Sales & Distribution at The Jackson Laboratory, based in Sacramento, CA where he focused on expanding global relationships and distribution for JAX Mice & Clinical Research Services. During his time in Sacramento with JAX, he served both as Director of Business Development and as Senior Site Director while the team closed down one site and simultaneously opened a much larger facility on budget / schedule. Paige was intimately involved with financing growth at JAX West, strategic planning for JAX and was Chairman of JAX West’s IACUC Committee. Prior to joining JAX, Mr. Paige was General Manager of Knight-Celotex, a 24/7/365 construction products manufacturing plant in Lisbon Falls, ME. He previously served as VP of Administration for the Neptune Regional Transmission System during its development stages and subsequent $650 M project financing. Earlier in his career, Mr. Paige acted as financial analyst and controller for Cianbro Development Corporation and Atlantic Energy Partners, a subsidiary of The Cianbro Companies, and held positions in corporate marketing at Fairchild Semiconductor and as personal assistant to Governor Angus King (I) of Maine.
Mr. Paige received a B.A. from Middlebury College in Vermont and an M.B.A. from Babson College in Massachusetts. He currently splits his time between Explora’s operations in San Diego and San Francisco.
Richard Lin, PhD
Founder & Head of Growth Strategies
Dr. Richard Lin founded Explora’s research services and vivarium operations and now leads the company’s growth strategies. Richard is also very active in the San Diego biotech community: he is on the Planning Committee of the BIOCOM CRO Initiative, the Industry Advisory Board of the Southern California Biotech Center, and is a frequent speaker at local bioentrepreneur events.
Richard has more than 25 years of academic research and industry drug development experience, with extensive knowledge of cancer biology, metabolic diseases, and animal physiology. Prior to founding Explora BioLabs in 2004, Richard held leadership positions in research and preclinical development at Ansata Therapeutics, Genset Corporation, Corvas International, and Axys Pharmaceuticals. Richard conducted his postdoctoral research at UC San Diego Cancer Center, and received his PhD in Zoology from UC Berkeley.
Hong Xin, PhD
Chief Operating Officer
Dr. Hong Xin is in charge of all contract research at Explora. She guides clients and oversees studies from the initial project design, through execution and data analysis, to the final study report.
Hong has over 25 years of academic research and industry drug development experience, with in-depth knowledge across multiple disciplines including cancer biology, cell biology, immunotherapy, molecular biology, animal model development, and pharmacology. Prior to joining Explora BioLabs in 2007, Hong was the Director of Preclinical Pharmacology at Alexion Antibody Technologies, and a scientist in the Pharmacology Department at Chiron Corporation. Hong conducted her postdoctoral research at the Burnham Institute and Chiron Corporation, and received her PhD in Biological Chemistry from University of North Carolina at Chapel Hill.